President Biden in 2022 announced Admiral Linda Fagan as the new commandant of the U.S. Coast Guard making her the first woman to lead a branch of the U.S. military. President Trump's administration ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

An asthma drug taken by hundreds of thousands of Australians could increase the risk of suicide, research suggests.

The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

The FDA approved Spravato for those battling depression and has seen little to no improvement from two types of antidepressants.

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with ma ...

Johnson & Johnson has received FDA approval for Spravato nasal spray as the first and only monotherapy for adults with treatment-resistant depression.